SEC Form 4 · accession 0001437749-15-014055
Proto Labs Inc · PRLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacqueline D. Schneider
Officer — Vice President Global Sales
Period of report
Jul 23, 2015
Accepted (ET)
Jul 27, 2015 · 12:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001443669
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 23, 2015 | M | 5,000 | $5.56 | A | 11,729 | D | |
| Common Stock | Jul 23, 2015 | M | 14,000 | $7.86 | A | 25,729 | D | |
| Common Stock | Jul 23, 2015 | M | 7,142 | $30.58 | A | 32,871 | D | |
| Common Stock | Jul 23, 2015 | M | 3,858 | $47.08 | A | 36,729 | D | |
| Common StockF2 | Jul 23, 2015 | S | 8,846 | $73.1174 | D | 27,883 | D | |
| Common StockF3 | Jul 23, 2015 | S | 1,154 | $73.6662 | D | 26,729 | D | |
| Common StockF4 | Jul 23, 2015 | S | 10,000 | $74.5481 | D | 16,729 | D | |
| Common StockF5 | Jul 23, 2015 | S | 10,000 | $76.509 | D | 6,729 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F6 | $5.56 | Jul 23, 2015 | M | 5,000 | D | — | Apr 28, 2019 | Common Stock | 5,000 | 0 | D |
| Employee Stock Option (right to buy)F7 | $7.86 | Jul 23, 2015 | M | 14,000 | D | — | Dec 21, 2020 | Common Stock | 14,000 | 14,000 | D |
| Employee Stock Option (right to buy)F8 | $30.58 | Jul 23, 2015 | M | 7,142 | D | — | May 7, 2022 | Common Stock | 7,142 | 5,428 | D |
| Employee Stock Option (right to buy)F9 | $47.08 | Jul 23, 2015 | M | 3,858 | D | — | Feb 15, 2023 | Common Stock | 3,858 | 12,312 | D |
Explanation of responses
- F1Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2015.
- F2Reflects the weighted average price of 8,846 shares of common stock of Proto Labs, Inc. sold by the reporting person on July 23, 2015 with sale prices ranging from $72.56 to $73.56 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Reflects the weighted average price of 1,154 shares of common stock of Proto Labs, Inc. sold by the reporting person on July 23, 2015 with sale prices ranging from $73.58 to $74.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Reflects the weighted average price of 10,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on July 23, 2015 with sale prices ranging from $74.50 to $74.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5Reflects the weighted average price of 10,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on July 23, 2015 with sale prices ranging from $76.50 to $76.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6Fully vested.
- F7The option vests as to 20% of the shares in five annual installments beginning on December 21, 2011.
- F8The option vests as to 20% of the shares in five annual installments beginning on May 7, 2013.
- F9The option vests as to 20% of the shares in five annual installments beginning on February 15, 2014.